FT Options’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$796K Sell
50,700
-19,000
-27% -$301K 1.2% 28
2017
Q2
$247K Sell
69,700
-26,900
-28% -$175K 0.43% 50
2017
Q1
$140K Buy
96,600
+30,700
+47% +$148K 0.18% 95
2016
Q4
$7K Buy
65,900
+31,900
+94% +$234K 0.01% 214
2016
Q3
$7K Buy
+34,000
New +$489K 0.01% 315
2016
Q1
Sell
-167,500
Closed -$209K 304
2015
Q4
$209K Buy
+167,500
New +$4.2M 0.15% 101

Other funds holding DVAX

FT Options's DVAX Position: Q3 2017 in Review

FT Options sold out of Dynavax Technologies (DVAX) in Q3 2017, closing a stake of 30,795 shares — an estimated $487K sold.

FT Options first reported a position in DVAX in Q4 2015 and held it in 4 quarters. The position peaked at $1.14M in Q4 2015. 119 funds tracked by Wall St. Rank hold DVAX as of Q3 2017.

  • FT Options reported no remaining Dynavax Technologies position as of Q3 2017 after selling out during the quarter.
  • FT Options sold 30,795 Dynavax Technologies shares in Q3 2017, an estimated $487K.
  • FT Options first reported a position in Dynavax Technologies in Q4 2015 and held it in 4 quarters.
  • FT Options's Dynavax Technologies position peaked at $1.14M in Q4 2015.
  • 119 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.